1. Home
  2. AGX vs AXSM Comparison

AGX vs AXSM Comparison

Compare AGX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$635.90

Market Cap

10.7B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$233.59

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
AXSM
Founded
1961
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.0B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
AGX
AXSM
Price
$635.90
$233.59
Analyst Decision
Buy
Strong Buy
Analyst Count
6
17
Target Price
$409.50
$211.12
AVG Volume (30 Days)
307.7K
873.8K
Earning Date
03-26-2026
05-04-2026
Dividend Yield
0.32%
N/A
EPS Growth
58.37
38.56
EPS
3.24
N/A
Revenue
$944,606,000.00
N/A
Revenue This Year
$33.81
$57.24
Revenue Next Year
$20.97
$55.88
P/E Ratio
$211.94
N/A
Revenue Growth
8.06
N/A
52 Week Low
$196.90
$96.09
52 Week High
$805.75
$260.19

Technical Indicators

Market Signals
Indicator
AGX
AXSM
Relative Strength Index (RSI) 40.87 44.41
Support Level $591.58 $217.15
Resistance Level $768.89 $236.26
Average True Range (ATR) 44.75 9.92
MACD -13.97 -1.50
Stochastic Oscillator 1.86 17.27

Price Performance

Historical Comparison
AGX
AXSM

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: